1. Home
  2. EYEN vs OBLG Comparison

EYEN vs OBLG Comparison

Compare EYEN & OBLG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EYEN
  • OBLG
  • Stock Information
  • Founded
  • EYEN 2014
  • OBLG 2000
  • Country
  • EYEN United States
  • OBLG United States
  • Employees
  • EYEN N/A
  • OBLG N/A
  • Industry
  • EYEN Biotechnology: Pharmaceutical Preparations
  • OBLG Computer Software: Programming Data Processing
  • Sector
  • EYEN Health Care
  • OBLG Technology
  • Exchange
  • EYEN Nasdaq
  • OBLG Nasdaq
  • Market Cap
  • EYEN 3.7M
  • OBLG 3.8M
  • IPO Year
  • EYEN 2018
  • OBLG N/A
  • Fundamental
  • Price
  • EYEN $1.12
  • OBLG $3.33
  • Analyst Decision
  • EYEN Hold
  • OBLG
  • Analyst Count
  • EYEN 4
  • OBLG 0
  • Target Price
  • EYEN $2.00
  • OBLG N/A
  • AVG Volume (30 Days)
  • EYEN 495.7K
  • OBLG 7.0K
  • Earning Date
  • EYEN 05-14-2025
  • OBLG 05-07-2025
  • Dividend Yield
  • EYEN N/A
  • OBLG N/A
  • EPS Growth
  • EYEN N/A
  • OBLG N/A
  • EPS
  • EYEN N/A
  • OBLG N/A
  • Revenue
  • EYEN $31,832.00
  • OBLG $2,378,000.00
  • Revenue This Year
  • EYEN $23,413.60
  • OBLG N/A
  • Revenue Next Year
  • EYEN $400.98
  • OBLG N/A
  • P/E Ratio
  • EYEN N/A
  • OBLG N/A
  • Revenue Growth
  • EYEN 2557.09
  • OBLG N/A
  • 52 Week Low
  • EYEN $1.06
  • OBLG $2.81
  • 52 Week High
  • EYEN $124.80
  • OBLG $14.80
  • Technical
  • Relative Strength Index (RSI)
  • EYEN 27.91
  • OBLG 43.13
  • Support Level
  • EYEN $1.06
  • OBLG $3.18
  • Resistance Level
  • EYEN $1.19
  • OBLG $3.58
  • Average True Range (ATR)
  • EYEN 0.10
  • OBLG 0.20
  • MACD
  • EYEN 0.05
  • OBLG 0.00
  • Stochastic Oscillator
  • EYEN 9.05
  • OBLG 39.55

About EYEN Eyenovia Inc.

Eyenovia Inc is a clinical stage ophthalmic company developing a pipeline of therapeutics based on its propriety array print (MAP) platform technology. It aims to achieve clinical microdosing of next-generation formulations of novel and existing ophthalmic pharmaceutical agents using its high-precision targeted ocular delivery system, branded the Opejet, which has the potential to replace conventional eye dropper delivery and improve safety, tolerability, patient compliance and topical delivery success for ophthalmic eye treatments. Using its proprietary delivery technology, Eyenovia is developing the next generation of smart ophthalmic therapies which target new indications or new combinations.

About OBLG Oblong Inc.

Oblong Inc is a provider of patented multi-stream collaboration products and managed services for video collaboration and network solutions. The company's flagship product Mezzanine is the technology platform that defines computing: simultaneous multi-user, multi-screen, multi-device, and multi-location for dynamic and immersive visual collaboration. Mezzanine transforms routine meetings and workflows into agile, engaging experiences by making data visible and accessible in a collaborative setting. Mezzanine enables multiple, concurrent pieces of content to be shared, manipulated, created, and captured across distance. It serves various industries including aerospace, consulting, executive search, broadcast media, technology, financial services, education, healthcare, real estate.

Share on Social Networks: